Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis

Journal of Liposome Research

Volumn 20, Issue 4, 2010, Pages 341-350

  Gupta, Madhu ^a   Goyal, Amit K ^a   Paliwal, Shivani Rai ^a   Paliwal, Rishi ^a   Mishra, Neeraj ^a   Vaidya, Bhuvaneshwar ^a   Dube, Devyani ^a   Jain, Sanjay K ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Carbopol gel; Fluconazole; Localized effect; Topical delivery

Indexed keywords

CARBOMER; FLUCONAZOLE; LIPOSOME; NIOSOME; NONIONIC SURFACTANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; COLONY FORMING UNIT; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; FILM; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LIPID VESICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN CANDIDIASIS; SKIN IRRITATION; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIFUNGAL AGENTS; BIOCOMPATIBLE MATERIALS; CANDIDIASIS, CUTANEOUS; DRUG DELIVERY SYSTEMS; FLUCONAZOLE; GELS; LIPOSOMES; MALE; MATERIALS TESTING; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SURFACE-ACTIVE AGENTS;

EID: 78049473820     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982101003596125     Document Type: Article

References (48)

1. Abdel-Mottaleb, M. M. A., Mortada, N. D., El-Shamy, A. A., Awad, G. A. S. (2009). Physically cross-linked polyvinyl alcohol for the topical delivery of fluconazole. Drug Dev Ind Pharm 35:311-320.
2. Agarwal, R., Katare, O. P., Vyas, S. P. (2001). Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 228:43-52.
3. Alekha, K. D., William, F. E. (2006). Fluconazole. In: Florey, K. (Ed.), Analytical profiles of drug substances and excipients (57-113). Academic Press, London, UK.
4. Bidkar, S., Jain, D., Padsalg, A., Patel, K., Mokale, V. (2007). Formulation development and evaluation of fluconazole gel in various polymer bases. As J Pharma 1:63-68.
5. Bouwstra, J. A., Honeywell-Nguyen, P. L., Gooris, G. S., Ponec, M. (2003). Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 42:1-36.
6. Calzavara-Pinton, P. G., Venturini, M., Sala, R. A. (2005). Comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobio B Bio 78:1-6.
7. Donnelly, R., McCarron, P., Tunney, M. (2008). Antifungal photodynamic therapy. Microbiol Res 163:1-12.
8. Fang, J. Y., Hong, C. T., Chiu, W. T., Wang, Y. Y. (2001). Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61-72.
9. Foong, W. C., Harsanyi, B. B., Mezei, M. (1990). Biodisposition and histological evaluation of topically applied retinoic acid in liposomal, cream, and gel dosage forms. In: Hanin, I., Pepeu, G. (Eds.), Phospholipids (pp 139-154). New York: Plenum Press.
10. Grant, S. M., Clissold, S. P. (1990). Fluconazole: a review of its pharmacodynamic and pharmacokinectic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39:877-916.
11. Gupta, P. N., Mishra, V., Rawat, A., Dubey, P., Mahor, S., Jain, S., Chatterji, D. P., Vyas, S. P. (2005). Noninvasive vaccine delivery in transfersomes, niosomes, and liposomes: a comparative study. Int J Pharm 293:73-82.
12. Ibrahim, A. A., Bosela, A. A., Ahmed, S. M., Mahrous, G. M. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 59:485-490.
13. Jadhav, K. R., Kadam, V. J., Pisal, S. S. (2009). Formulation and evaluation of lecithin organogel for topical delivery of fluconazole. Curr Drug Deliv 6:174-183.
14. Junginger, H. E., Hofland, H. E. J., Bouwstra, J. A.(1991). Liposomes and niosomes interactions with human skin. Cosmet Toil 105:45-50.
15. Kim, M. K., Chung, S. J., Lee, M. H., Cho, A. R, Shim, C. K. (1997). Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. J Contr Rel 46:243-251.
16. Laithy, H.M.E.I., EI-Shaboury, K. M. F. (2002). The development of cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS Pharmsci 3:1-9.
17. Lawrence, M. J., Chauhan, S., Lawrence, S. M., Barlow, D. J. (1996). The formation, characterization, and stability of nonionic surfactant vesicles. STP Pharm Sci 6:49-60.
18. Maebashi, K., Toyama, T., Uchida, K., Yamaguchi, H. (1995). A novel model of cutaneous candidiasis produced in prednisolonetreated guinea pigs. J Med Vet Mycol 19:390-392.
19. Manconi, M., Sinico, C., Valenti, D., Lai, F., Fadda, A. M. (2006). Niosomes as carriers for tretinoin III.A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 311:11-19.
20. Manosroi, A., Jantrawut, P., Manosroi, J. (2008). Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 360:156-163.
21. Manosroi, A., Kongkaneramit, L., Manosroi,. J. (2004). Stability and transdermal absorption of topical amphotericin-B liposome formulations. Int J Pharm 270:279-86.
22. Manosroi, A., Wongtrakul, P., Manosroi, J., Sakai, H., Sugawara, F., Yuasa, M., Abe, M. (2003). Characterization of vesicles prepared with various nonionic surfactants mixed with cholesterol. Coll Sur B Bioint 30:129-138.
23. Mitragotri, S. (2000). In situ determination of partition and diffusion coefficients in the lipid bilayers of stratum corneum. Pharm Res 17:1026-1029.
24. Murdan, S. (2002). Drug delivery to the nail following topical application. Int J Pharm 236:1-26.
25. Ning, M., Guo, Y., Pan, H., Chen, X., Zhongwei, G. (2005). Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm 31:375-383.
26. Ning, M., Guo, Y., Pan, H., Yu, H., Zhongwei, G. (2005). Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull 53:620-624.
27. Pavelic, Z., Skalko-Basnet, N., Schubert, R. (2001). Liposomal gels for vaginal drug delivery. Int J Pharm 219:139-149.
28. Qiu, Y., Gao, Y., Hu, K., Li, F. (2008). Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Contr Rel 129:144-150.
29. Rai, S., Paliwal, R., Vaidya, B., Khatri, K., Goyal, A. K., Gupta, P. N., Vyas, S. P. (2008). Targeted delivery of doxorubicin via estroneappended liposome. J Drug Targ 16:455-463.
30. Ramsdale, M. (2008). Programmed cell death in pathogenic fungi. Biochim Biophys Acta 1783:1369-1380.
31. Ruhnke, M., Hartwig, K., Kofla, G. (2008). New options for treatment of candidaemia in critically ill patients. Clin Microbiol Infect 14:46-54.
32. Satturwar, P. M., Khandare, J. N., Nande, V. S. (2001). Niosomal delivery of ketoconazole. Ind Drugs 38:620-624.
33. Schmid, M. H., Korting, H. C. (1996). Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev 18:335-342.
34. Schreier, H., Bouwstra, J. (1994). Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Contr Rel 30:l-15.
35. Segal, E., Elad, D. (2006). Fungal vaccines and immunotherapy. J Med Mycol 16:134-151.
36. Shah, K. A., Date, A. A., Joshi, M. D., Patravale, V. B. (2007). Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 345:163-171.
37. Shao, P., Huanga, L., Hsueh, P. (2007). Recent advances and challenges in the treatment of invasive fungal infections. Int J Antimicob Agents 30:487-495.
38. Singh, R., Vyas, S. P. (1996). Topical liposomal system for localized and controlled drug delivery. J Dermatol Sci 13:107-111.
39. Sinico, C., Manconi, M., Peppi, M., Lai, F., Valenti, D., Fadda, A. M. (2005). Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Contr Rel 103:123-136.
40. Song, Y., Kim, C. (2006). Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 27:271-280.
41. Soni, N., Wagstaff, A. (2005). Fungal infection: focus on critical care: antibiotics and ICU. Curr Anaes Crit Care16:231-241.
42. Tabbakhian, M., Tavakoli, N., Jaafari, M. R., Daneshamouza, S. (2006). Enhancement of follicular delivery of finasteride by liposomes and niosomes I. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 323:1-10.
43. Uchegbu, I. F., Vyas, S. P. (1998). Nonionic surfactant-based vesicles (niosomes) in drug delivery. Int J Pharm 172:33-70.
44. Wattananat, T., Akarawut, W. (2006). Validated HPLC method for the determination of fluconazole in human plasma. Biomed Chromat 20:1-3.
45. Williams, A. (2003). Transdermal and topical drug delivery, 1st ed. London: Pharmaceutical Press.
46. Williams, A. C., Barry, B. W. (1991). The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int J Pharm 74:157-168.
47. Yimei, J., Jolya, L., Omria, A. (2008). Liposomes as a carrier for gentamicin delivery: development and evaluation of the physicochemical properties. Int J Pharm 59:254-263.
48. Zhang, A. Y., Camp, W. L., Elewski, B. E. (2007). Advances in topical and systemic antifungals. Dermatol Clin 25:165-183.